Acadian Asset Management LLC Biomarin Pharmaceutical Inc Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 12,730 shares of BMRN stock, worth $848,199. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,730
Previous 12,113 5.09%
Holding current value
$848,199
Previous $994,000 10.26%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$69.02 - $93.84 $42,585 - $57,899
617 Added 5.09%
12,730 $892,000
Q2 2024

Aug 06, 2024
BUY
$74.43 - $92.22 $712,741 - $883,098
9,576 Added 377.45%
12,113 $994,000
Q1 2024

May 10, 2024
BUY
$83.81 - $99.0 $52,381 - $61,875
625 Added 32.69%
2,537 $221,000
Q4 2023

Feb 13, 2024
SELL
$76.22 - $98.51 $134,909 - $174,362
-1,770 Reduced 48.07%
1,912 $184,000
Q3 2023

Nov 13, 2023
BUY
$85.07 - $94.48 $141,216 - $156,836
1,660 Added 82.1%
3,682 $325,000
Q2 2023

Aug 07, 2023
BUY
$86.68 - $100.3 $175,266 - $202,806
2,022 New
2,022 $175,000
Q2 2022

Aug 09, 2022
BUY
$71.48 - $86.85 $831,240 - $1.01 Million
11,629 Added 2698.14%
12,060 $1 Million
Q1 2022

May 12, 2022
BUY
$74.28 - $92.69 $25,552 - $31,885
344 Added 395.4%
431 $32,000
Q4 2021

Feb 10, 2022
SELL
$71.72 - $91.47 $23.1 Million - $29.4 Million
-321,579 Reduced 99.97%
87 $7,000
Q3 2021

Nov 12, 2021
BUY
$74.77 - $85.47 $21.3 Million - $24.4 Million
285,148 Added 780.84%
321,666 $24.8 Million
Q2 2021

Aug 11, 2021
BUY
$75.51 - $84.79 $1.32 Million - $1.49 Million
17,527 Added 92.29%
36,518 $3.05 Million
Q1 2021

May 11, 2021
SELL
$74.73 - $90.69 $1.82 Million - $2.21 Million
-24,346 Reduced 56.18%
18,991 $1.43 Million
Q4 2020

Feb 11, 2021
BUY
$72.61 - $90.2 $1.43 Million - $1.77 Million
19,677 Added 83.17%
43,337 $3.8 Million
Q3 2020

Nov 09, 2020
BUY
$71.87 - $131.03 $221,503 - $403,834
3,082 Added 14.98%
23,660 $1.8 Million
Q2 2020

Aug 12, 2020
BUY
$79.55 - $124.22 $1.56 Million - $2.43 Million
19,596 Added 1995.52%
20,578 $2.54 Million
Q1 2020

May 11, 2020
BUY
$71.37 - $96.85 $70,085 - $95,106
982 New
982 $83,000

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email